In a recent work, new gene and protein biomarkers CHI3L1, IL-8, IL-10, MSR1, PHLDA1, PI3, and SERPINB2, were proposed to discriminate healthy control subjects from nonallergic asthmatic patients (T2-low) and to measure asthma severity (20). This evidence concerns the gene SERPINB2 and asthma.